Enhancing Outcomes and Reducing Treatment Burden with Advanced Therapies in Neovascular AMD and DME : Episode 3
Treat-and-Extend Strategy With Aflibercept
Panelists discuss how treat-and-extend dosing with aflibercept 2 mg allows for individualized treatment intervals while maintaining vision gains. However, optimal extension timing must be carefully determined based on disease activity markers.
Video content above is prompted by the following:
- What has been your experience using the treat-and-extend strategy with aflibercept 2 mg?
Related Content
